IndraLab
Statements
reach
"Loss of SMAD4 was associated with both decreased median disease-free survival (28months; 95% confidence interval, 16-40) months compared with 223months (95% confidence interval, 3-443months) for SMAD4 positive patients (P =.03) and decreased median disease specific survival (SMAD4 : 137 [95% confidence interval, 81-194] months versus SMAD4 positive : 204 [95% confidence interval, 143-264] months; P =.04)."